Target type: biologicalprocess
The directed movement of copper (Cu) ions into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. [GOC:ai]
Copper ion transport is a fundamental biological process that ensures the proper delivery and utilization of copper, an essential trace element. It involves a series of intricate steps orchestrated by specialized transmembrane proteins known as copper transporters. These proteins facilitate the movement of copper ions across cellular membranes, maintaining the delicate balance of copper levels within cells and tissues.
The journey of copper ions begins with their uptake from the extracellular environment. This step is primarily mediated by high-affinity copper transporters, such as Ctr1 in mammals and CTR1 in yeast. These proteins exhibit a unique structure with multiple transmembrane domains and a metal-binding site. Ctr1/CTR1 actively bind copper ions and deliver them to the intracellular compartment.
Once inside the cell, copper ions embark on a journey through a network of specialized chaperone proteins. These chaperones, such as Atx1 in yeast and Atox1 in mammals, escort copper ions to specific cellular destinations. They achieve this by forming transient complexes with copper ions, preventing their inappropriate interactions and ensuring their safe passage.
The ultimate destination of copper ions is often a specific enzyme or protein that requires copper for its activity. These copper-dependent proteins play crucial roles in a wide range of biological processes, including respiration, antioxidant defense, and neurotransmission. To facilitate the incorporation of copper into these proteins, specialized copper chaperones, such as Cox17 and CCS, deliver copper ions to the appropriate sites.
The regulation of copper ion transport is essential for maintaining cellular homeostasis. Excess copper can be toxic, while deficiency can lead to various physiological impairments. To mitigate these risks, cells have developed intricate mechanisms to tightly control copper uptake, distribution, and excretion. These mechanisms involve feedback loops, regulatory proteins, and specialized copper exporters, such as ATP7A and ATP7B in mammals.
Copper ion transport is a highly regulated and dynamic process that plays a critical role in maintaining cellular health and function. Disruptions in this process can lead to a variety of diseases, emphasizing the importance of understanding the intricate mechanisms involved.'
"
Protein | Definition | Taxonomy |
---|---|---|
Peptidyl-prolyl cis-trans isomerase FKBP4 | A peptidyl-prolyl cis-trans isomerase FKBP4 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q02790] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
cycloheximide | cycloheximide : A dicarboximide that is 4-(2-hydroxyethyl)piperidine-2,6-dione in which one of the hydrogens attached to the carbon bearing the hydroxy group is replaced by a 3,5-dimethyl-2-oxocyclohexyl group. It is an antibiotic produced by the bacterium Streptomyces griseus. Cycloheximide: Antibiotic substance isolated from streptomycin-producing strains of Streptomyces griseus. It acts by inhibiting elongation during protein synthesis. | antibiotic fungicide; cyclic ketone; dicarboximide; piperidine antibiotic; piperidones; secondary alcohol | anticoronaviral agent; bacterial metabolite; ferroptosis inhibitor; neuroprotective agent; protein synthesis inhibitor |
3-(3-pyridyl)-1-propyl-(2s)-1-(3,3-dimethyl-1,2-dioxopentyl)-2-pyrrolidinecarboxylate | |||
biricodar | biricodar: a non-macrocyclic ligand for FKBP12; structure in first source | alpha-amino acid ester | |
pd 407824 | |||
l 683590 | immunomycin: from Streptomyces hygroscopicus; structure given in first source | ether; lactol; macrolide; secondary alcohol | antifungal agent; bacterial metabolite; immunosuppressive agent |
cyclosporine | ramihyphin A: one of the metabolites produced by Fusarium sp. S-435; RN given refers to cpd with unknown MF | homodetic cyclic peptide | anti-asthmatic drug; anticoronaviral agent; antifungal agent; antirheumatic drug; carcinogenic agent; dermatologic drug; EC 3.1.3.16 (phosphoprotein phosphatase) inhibitor; geroprotector; immunosuppressive agent; metabolite |
timcodar | timcodar: a mutlidrug resistance inhibitor; structure in first source |